GE HealthCare Technologies Inc. GEHC
GE HealthCare Technologies Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($48.19); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
GE HealthCare Technologies Inc. trades at about 15.9× earnings — below its 10-year norm (10-year range 16.5×–24.2×, median 20.3×).
Shaded band = 10-year range (16.5×–24.2×); dot = today's 15.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 40.0% | 41.7% | 40.5% | 39.1% |
| Operating margin | 13.4% | 13.3% | 12.5% | 13.8% |
| Net margin | 10.1% | 10.1% | 8.0% | 10.4% |
| Return on assets | 5.6% | 6.0% | 4.8% | 7.0% |
| Return on equity | 20.1% | 23.5% | 21.9% | 20.5% |
| Debt / equity | 0.96× | 1.06× | 1.32× | 0.88× |
| Current ratio | 1.37 | 1.04 | 1.05 | 1.16 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.